TY - JOUR
T1 - Immunoregulatory characteristics of the in vitro anti-ssDNA response
AU - Anderson, Colin C.
AU - Panoskaltsis, Angela
AU - Sinclair, Nicholas R StC
PY - 1993/12/1
Y1 - 1993/12/1
N2 - Continuous blockade of B-cell antigen receptors (BCRs) with Fab αsIg prevents the anti-ssDNA response of high, but not low, density B cells. Signaling via the BCRs, by prior exposure to crosslinking F(ab′)2 αsIg, had no effect on the spontaneous anti-DNA response, but prevented a lipopolysaccharide-induced anti-DNA response. Pretreatment with intact αsIg, which provides exogenously derived Fc signals, reduced the response. An Fc-signal-blocking agent, F(ab′)2 anti-IgG-Fc antibody, increased the number of anti-DNA antibody-forming cells produced in the absence of exogenous IgG anti-ssDNA antibody. Thus, activation is dependent on the availability of the BCRs, prior BCR crosslinking does not interfere with activation, and endogenous IgG anti-ssDNA antibody limits the activation of anti-ssDNA-specific B cells most of which are T-cell independent. These results indicate that the anti-ssDNA response is driven through the BCR.
AB - Continuous blockade of B-cell antigen receptors (BCRs) with Fab αsIg prevents the anti-ssDNA response of high, but not low, density B cells. Signaling via the BCRs, by prior exposure to crosslinking F(ab′)2 αsIg, had no effect on the spontaneous anti-DNA response, but prevented a lipopolysaccharide-induced anti-DNA response. Pretreatment with intact αsIg, which provides exogenously derived Fc signals, reduced the response. An Fc-signal-blocking agent, F(ab′)2 anti-IgG-Fc antibody, increased the number of anti-DNA antibody-forming cells produced in the absence of exogenous IgG anti-ssDNA antibody. Thus, activation is dependent on the availability of the BCRs, prior BCR crosslinking does not interfere with activation, and endogenous IgG anti-ssDNA antibody limits the activation of anti-ssDNA-specific B cells most of which are T-cell independent. These results indicate that the anti-ssDNA response is driven through the BCR.
KW - Anti-ssDNA antibody
KW - Antigen receptor, B-cell
KW - B-cell Fc receptor
KW - End-product feedback
KW - Fc signaling
KW - Fc-signal blockade
KW - Lipopolysaccharide activation
UR - http://www.scopus.com/inward/record.url?scp=0027731379&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027731379&partnerID=8YFLogxK
U2 - 10.1007/BF02935508
DO - 10.1007/BF02935508
M3 - Article
C2 - 8151158
AN - SCOPUS:0027731379
SN - 0257-277X
VL - 12
SP - 349
EP - 357
JO - Immunologic Research
JF - Immunologic Research
IS - 4
ER -